drugset
drugset / Trial / NCT04618965

Intrathecal Versus Intravenous Dexmeditomedine in Transurethral Resection of the Prostate

NCT04618965 ↗

Phase 4 Unknown 75 enrolled Tanta University
RandomizedParallel-groupDouble-blindTreatment

Summary

This study is to evaluate The analgesic effect of intrathecal versus intravenous dexmeditomedine in transurethral resection of the prostate

Timeline

Start
2020-11-01
Primary completion
2021-04-26
Completion
2021-06-26

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.4 ug/kg Intrathecal
Subject Dexmedetomidine Other / unclassified 5 ug Intrathecal

Indications

No indication recorded.